$1.5 Billion is the total value of Eversept Partners, LP's 87 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FREQ | Exit | FREQUENCY THERAPEUTICS INCcall | $0 | – | -10,000 | -100.0% | -0.01% | – |
| Exit | APTOSE BIOSCIENCES INC | $0 | – | -80,000 | -100.0% | -0.04% | – | |
| OTIC | Exit | OTONOMY INCcall | $0 | – | -198,400 | -100.0% | -0.04% | – |
| QDEL | Exit | QUIDEL CORP | $0 | – | -4,132 | -100.0% | -0.04% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -12,900 | -100.0% | -0.04% | – |
| IMMP | Exit | IMMUTEP LTDsponsored ads | $0 | – | -249,895 | -100.0% | -0.06% | – |
| CABA | Exit | CABALETTA BIO INC | $0 | – | -76,849 | -100.0% | -0.06% | – |
| IFRX | Exit | INFLARX NV | $0 | – | -268,634 | -100.0% | -0.08% | – |
| RAD | Exit | RITE AID CORP | $0 | – | -54,025 | -100.0% | -0.08% | – |
| CHWY | Exit | CHEWY INCcl a | $0 | – | -13,100 | -100.0% | -0.08% | – |
| Exit | CONFORMIS INC | $0 | – | -1,541,978 | -100.0% | -0.12% | – | |
| KROS | Exit | KEROS THERAPEUTICS INC | $0 | – | -27,631 | -100.0% | -0.13% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -68,575 | -100.0% | -0.13% | – |
| XGN | Exit | EXAGEN INC | $0 | – | -104,437 | -100.0% | -0.14% | – |
| SRDX | Exit | SURMODICS INC | $0 | – | -47,906 | -100.0% | -0.20% | – |
| AMRN | Exit | AMARIN CORP PLCcall | $0 | – | -440,800 | -100.0% | -0.21% | – |
| CNC | Exit | CENTENE CORP DELcall | $0 | – | -50,000 | -100.0% | -0.24% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -93,280 | -100.0% | -0.26% | – |
| LMNX | Exit | LUMINEX CORP DEL | $0 | – | -135,471 | -100.0% | -0.33% | – |
| ARKG | Exit | ARK ETF TRput | $0 | – | -56,900 | -100.0% | -0.38% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -33,473 | -100.0% | -0.46% | – |
| MNKD | Exit | MANNKIND CORP | $0 | – | -2,165,383 | -100.0% | -0.64% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -35,886 | -100.0% | -0.74% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -420,000 | -100.0% | -0.82% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -345,717 | -100.0% | -1.16% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -242,172 | -100.0% | -1.24% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -68,383 | -100.0% | -1.25% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -163,114 | -100.0% | -1.29% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -465,983 | -100.0% | -5.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.